Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Highcroft Capital is a venture capital fund based in Wayzata, Minnesota, specializing in early-stage investments in medical technology (medtech) companies. Founded by a team of physician investors, the firm utilizes their industry insights and access to deal flow to evaluate companies from a user perspective. This unique approach allows them to identify promising innovations that can significantly impact healthcare.
The firm operates with a planned fund size ranging from $3 million to $5 million, focusing on game-changing products and technologies that have the potential to reshape the medical industry. Highcroft Capital's commitment to advancing the standard of care in healthcare is evident in their investment strategy, which emphasizes early-stage opportunities in North America.
Highcroft Capital concentrates on early-stage medical technology companies, specifically those that aim to advance the standard of care in healthcare. The fund targets investments in the pre-seed, seed, and seed-plus stages, with check sizes ranging from $3 million to $5 million. This investment strategy is designed to facilitate access to venture capital opportunities in the healthcare sector.
The firm seeks innovative products and technologies that can reshape the medical industry. Their physician-led team brings valuable insights into the medtech landscape, allowing them to evaluate potential investments from a user perspective. This focus on healthcare innovation positions Highcroft Capital as a key player in the early-stage investment space.
Highcroft Capital has not publicly disclosed specific portfolio companies. However, their investment strategy emphasizes early-stage medical technology firms that are poised to make significant advancements in healthcare. The firm is particularly interested in companies that are developing innovative solutions to improve patient care and outcomes.
Given their focus on the medtech sector, potential areas of investment may include companies involved in medical devices, diagnostics, and digital health solutions. Highcroft Capital's physician-led team is well-equipped to identify and support startups that align with their mission to enhance the standard of care.
Marc Newell, MD - Partner & Treasurer. Dr. Newell brings extensive medical expertise and investment experience to the firm, having previously worked in various healthcare settings.
Joshua Buckler, MD - Partner & Corporate Secretary. Dr. Buckler has a strong background in medicine and healthcare investments, contributing valuable insights to the firm's strategy.
Peter Eckman, MD - Partner & Investor Relations. Dr. Eckman focuses on building relationships with investors and portfolio companies, leveraging his medical background to enhance communication.
Brian O'Connell, BSEE/MBA - Managing Partner. O'Connell combines engineering and business expertise, providing a unique perspective on technology investments in healthcare.
David Madgett, JD - Partner & General Counsel. Madgett oversees legal matters and compliance, ensuring that the firm operates within regulatory frameworks.
To pitch to Highcroft Capital, founders should send an email to info@highcroftcapital.com. It is recommended to include a comprehensive pitch deck that outlines the business model, market opportunity, competitive landscape, and team qualifications. Founders should expect a response within a reasonable timeframe, although specific response times are not disclosed.
As of October 2023, Highcroft Capital has not publicly announced any recent investments, exits, or fund raises. The firm continues to focus on identifying promising early-stage medical technology companies in North America.
What are Highcroft Capital's investment criteria?
Highcroft Capital invests in early-stage medical technology companies, focusing on those that can advance the standard of care in healthcare. They target pre-seed, seed, and seed-plus stages with check sizes ranging from $3 million to $5 million.
How can I apply or pitch to Highcroft Capital?
Founders can pitch to Highcroft Capital by sending an email to info@highcroftcapital.com. It is advisable to include a detailed overview of the business, the problem it addresses, and how it aligns with their investment focus.
What makes Highcroft Capital different from other venture capital firms?
The firm is founded and led by physician investors, providing unique insights into the medical technology landscape. This background allows them to evaluate companies from a user perspective, which is a distinct advantage in the healthcare sector.
What is the geographic scope of Highcroft Capital's investments?
Highcroft Capital primarily focuses on early-stage medical technology companies located in North America. This geographic focus allows them to leverage their network and industry knowledge effectively.
What is Highcroft Capital's post-investment involvement like?
While specific details on post-investment involvement are not disclosed, the firm's physician-led team is likely to provide valuable insights and support to portfolio companies, particularly in navigating the healthcare landscape.
What is the typical check size for investments?
Highcroft Capital typically invests between $3 million and $5 million in early-stage medical technology companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.